Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer
Phase III
· Site: SITE002 (USA) (Dr. Nolan)
· consented 2022-12-16
Adverse events
4
Serious AEs
1
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Grade 1 Hypothyroidism — outcome: RECOVERED/RESOLVED; onset 2023-03-26 (study day 94); relationship: not assessed
severe
serious
assessed
2026-08-18
Grade 4 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-05-23 (study day 152); relationship: N; serious criteria: life-threatening
mild
assessed
2026-08-18
Grade 1 Constipation — outcome: RECOVERED/RESOLVED; onset 2023-06-27 (study day 187); relationship: not assessed
moderate
assessed
2026-08-18
Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2024-03-17 (study day 451); relationship: not assessed
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.